Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Carcinoma, Renal Cell 13Melanoma 7Neoplasms 3Sarcoma, Kaposi 2Pancreatic Neoplasms 2Neoplasm Metastasis 2Multiple Myeloma 2Lymphoma 2Leukemia 2Kidney Neoplasms 2Hematologic Neoplasms 2HIV Infections 2Brain Neoplasms 2Acquired Immunodeficiency Syndrome 2Uveal Melanoma 1Uterine Cervical Neoplasms 1Thrombocythemia, Essential 1Prostatic Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Polycythemia Vera 1Osteosarcoma 1Myeloproliferative Disorders 1Mycosis Fungoides 1Margins of Excision 1Lymphoma, T-Cell 1Lymphoma, Follicular 1Leukemia, Myeloid, Chronic-Phase 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Leukemia, Hairy Cell 1Hodgkin Disease 1

Interventions

Rituximab 12Tacrolimus 11Peripheral Blood Stem Cell Transplantation 10Mycophenolic Acid 9fludarabine phosphate 8Cyclophosphamide 8Whole-Body Irradiation 6Methotrexate 5Cyclosporine 5Antilymphocyte Serum 5Vemurafenib 4Methylprednisolone 4Cladribine 4Busulfan 4merphos 3Therapeutics 3Radiotherapy 3Alemtuzumab 3obinutuzumab 2ibrutinib 2fludarabine 2binimetinib 2aldesleukin 2Transplantation 2Specimen Handling 2Prednisone 2Melphalan 2Lenalidomide 2Interferon-alpha 2Filgrastim 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Leukemia, Hairy Cell × Interferon alpha-2 × Clear all
NCT00001567 2008-03-04

A Phase II Efficacy Study of Roferon-A in Hairy Cell Leukemia

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
56 enrolled
Other hematologic neoplasm

Leukemia, Hairy Cell, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡